New Haven, CT’s HistoRx, which is developing tissue-based diagnostics, announced it has closed a $6 million Series B funding round. The deal was led by Brook Venture Partners, and joined by Navigator Technology Ventures, The Roche Venture Fund, Commons Capital, and Maven Capital.

• Share on Facebook
• Share on Twitter
• LinkedIn
• Email
• Reprints

Trending on Xconomy

• Merck And The Future of Immuno-Oncology: A Chat With Roger Perlmutter
• Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
• Teradata Names Oliver Ratzesberger as New CEO